REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 132 filers reported holding REVANCE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $557,000 | +139.1% | 20,619 | +146.8% | 0.01% | +133.3% |
| Q3 2021 | $233,000 | -15.0% | 8,355 | -9.5% | 0.01% | -33.3% |
| Q2 2021 | $274,000 | -30.6% | 9,228 | -41.3% | 0.01% | -62.5% |
| Q3 2020 | $395,000 | -15.6% | 15,718 | -18.1% | 0.02% | -25.0% |
| Q2 2020 | $468,000 | +32.2% | 19,180 | -19.7% | 0.03% | +10.3% |
| Q1 2020 | $354,000 | -49.5% | 23,900 | -44.7% | 0.03% | -52.5% |
| Q4 2019 | $701,000 | +109.3% | 43,200 | +297.1% | 0.06% | +52.5% |
| Q1 2018 | $335,000 | – | 10,878 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $42,779,000 | 61.17% |
| Essex Woodlands Management, Inc. | 3,342,047 | $91,739,000 | 21.30% |
| Sio Capital Management, LLC | 101,292 | $2,780,000 | 1.54% |
| Fosun International Ltd | 472,532 | $12,971,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 203,181 | $5,577,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 1,804,275 | $49,527,000 | 0.46% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 87,355 | $2,398,000 | 0.30% |
| FOX RUN MANAGEMENT, L.L.C. | 18,477 | $507,000 | 0.16% |
| Phoenix Investment Adviser LLC | 2,400 | $66,000 | 0.12% |
| Quinn Opportunity Partners LLC | 33,100 | $909,000 | 0.12% |